Connect with us

Cannabis

Medical Cannabis Market Size, Share, Growth Analysis, Global Trends, Industry Overview, Regional Forecast by 2027|Top Leaders-Aurora Cannabis, Aphria Medical Cannabis, MedReleaf Corp, Medical Marijuana: Says DBMR Analyst

GlobeNewswire

Published

on

PUERTO RICO, July 14, 2020 (GLOBE NEWSWIRE) — DBMR recently introduced Global Medical Cannabis Market Size, Share, Growth, Industry Trends and Forecast to 2027 study with in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status to 2027. Medical Cannabis Market Research Report explores analyses of historical data along with Market Size, Share, Growth, Demand, and Revenue of the global medical cannabis and estimates the future trend of medical cannabis market on the basis of this detailed study. The study shares Medical Cannabis Market performance both in terms of volume and revenue and this factor which is useful & helpful to the business. This report also provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. The growth of the Medical Cannabis market was mainly driven by the increasing R&D spending across the world, however latest COVID scenario and economic slowdown have changed complete market dynamics.
DBMR Analyses the Medical Cannabis Market to account to USD 82.19 billion by 2027 growing at a CAGR of 20.25% in the forecast period. Increasing awareness about the advantages of cannabis is expected to create new opportunity for the market.Get Exclusive Sample (350 Pages PDF) Report along with Tables and Figure and Pie Chart @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-medical-cannabis-marketGlobal Medical Cannabis Market Report 2020 (value and volume) by company, regions, product types, end industries, history data and estimate data. In addition, Report contains a comprehensive analysis of the important segments like market opportunities, import/export details, market dynamics, key manufacturers, growth rate, and key regions. This report focuses on the Medical Cannabis in the Global market, especially in the United States, Europe, China, Japan, South Korea, North America, India. Medical Cannabis Market report categorizes the market based on manufacturers, regions, type, and application. Medical Cannabis Market reports offer a detailed assessment of the Medical Cannabis including enabling technologies, current market situation, market assumptions, restraining factors.The Global Medical Cannabis Market SWOT is provided for the international markets including progress trends, competitive landscape breakdown, and key in regions development status. Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed.Understand Post COVID-19 Impact and Opportunities of Medical Cannabis Market @ https://www.databridgemarketresearch.com/covid-19-impact/global-medical-cannabis-marketA collective analysis on Medical Cannabis offers an exhaustive study supported current trends influencing this vertical throughout assorted geographies. Key information regarding market size, market share, statistics, application, and revenue is within the research to develop an ensemble prediction. Additionally, this research offers an in-depth competitive analysis that specializes in business outlook emphasizing expansion strategies accepted by market majors.The facts and data are represented in the report using diagrams, graphs, pie charts, and other pictorial representations. This enhances the visual representation and helps in understanding the facts much better.Visit here to In-Depth Research study Report https://www.databridgemarketresearch.com/reports/global-medical-cannabis-market Top Key Players of Medical Cannabis Market Report areCanopy Growth CorporationGW Pharmaceuticals plc.Aurora CannabisAphria Medical CannabisMedReleaf CorpCanniMed LtdUnited CannabisThe Peace Naturals Project IncMedical Marijuana, IncBOL PharmaCresco LabsAccess Full Report @ https://www.databridgemarketresearch.com/checkout/buy/singleuser/global-medical-cannabis-marketThe report also focuses on global major leading industry players of Global Medical Cannabis market providing information such as company profiles, product picture and specification, price, capacity, cost, production, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. With tables and figures helping analyze worldwide Global Medical Cannabis market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market. The Global Medical Cannabis market development trends and marketing channels are analyzed. Finally, the feasibility of new investment projects is assessed and overall research conclusions offered.Key Segmentation of Medical Cannabis Market:Medical Cannabis Market Segments by SpeciesCannabis IndicaSativaHybridMedical Cannabis Market Segments by DerivativesCannabidiol (CBD)Tetrahydrocannabinol (THC)OthersMedical Cannabis Market Segments by ApplicationPharmaceutical IndustryResearch and Development Centers OtherMedical Cannabis Market Segments by Route of AdministrationOral SolutionsCapsulesSmokingVaporizersTopicalsOthersMedical Cannabis Market Segments by GeographyNorth AmericaEuropeAsia PacificLatin AmericaMiddle East & AfricaFor More Information or Query and Looking for Customization click on below link and drop message @ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-medical-cannabis-marketGlobal Medical Cannabis Market Scope and Market SizeMedical cannabis market is segmented of the basis of species, derivatives, application and route of administration. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.Based on species, the medical cannabis market is segmented into cannabis indica, sativa and hybrid.Derivatives segment of the medical cannabis market is segmented into cannabidiol (CBD), tetrahydrocannabinol (THC), and others.The application segment of the medical cannabis market is divided into pharmaceutical industry, research and development centers and others.Based on route of administration, the medical cannabis market is bifurcated into oral solutions and capsules, smoking, vaporizers, topicals and others.This Medical Cannabis Market Research/analysis Report Contains Answers to your following Questions1. Which Manufacturing Technology is used for Medical Cannabis? What Developments Are Going On in That Technology? Which Trends Are Causing These Developments?
2. Who Are the Global Key Players in This Medical Cannabis Market? What is Their Company Profile, Their Product Information, and Contact Information?
3. What Was Global Market Status of Medical Cannabis Market? What Was Capacity, Production Value, Cost and PROFIT of Medical Cannabis Market?
4. What Is Current Market Status of Medical Cannabis Industry? What’s Market Competition in This Industry, Both Company, and Country Wise? What’s Market Analysis of Medical Cannabis Market by Taking Applications and Types in Consideration?
5. What Are Projections of Global Medical Cannabis Industry Considering Capacity, Production and Production Value? What Will Be the Estimation of Cost and Profit? What Will Be Market Share, Supply and Consumption? What about Import and Export?
6. What Is Medical Cannabis Market Chain Analysis by Upstream Raw Materials and Downstream Industry?
7. What Is Economic Impact On Medical Cannabis Industry? What are Global Macroeconomic Environment Analysis Results? What Are Global Macroeconomic Environment Development Trends?
8. What Are Market Dynamics of Medical Cannabis Market? What Are Challenges and Opportunities?
9. What Should Be Entry Strategies, Countermeasures to Economic Impact, Marketing Channels for Medical Cannabis Industry?
Still want to know more details Speak to Report Author @ https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-medical-cannabis-marketStrategic Points Covered in Table of Content of Global Medical Cannabis Market:1. Chapter 1: Introduction, market driving force product Objective of Study and Research Scope the Medical Cannabis market
2. Chapter 2: Exclusive Summary – the basic information of the Medical Cannabis Market.
3. Chapter 3: Displaying the Market Dynamics- Drivers, Trends and Challenges of the Medical Cannabis
4. Chapter 4: Presenting the Medical Cannabis Market Factor Analysis Porters Five Forces, Supply/Value Chain, PESTEL analysis, Market Entropy, Patent/Trademark Analysis.
5. Chapter 5: Displaying market size by Type, End User and Region 2010-2019
6. Chapter 6: Evaluating the leading manufacturers of the Medical Cannabis market which consists of its Competitive Landscape, Peer Group Analysis, BCG Matrix & Company Profile
7. Chapter 7: To evaluate the market by segments, by countries and by manufacturers with revenue share and sales by key countries (2020-2027).
8. Chapter 8 & 9: Displaying the Appendix, Methodology and Data Source
9. Finally, Medical Cannabis Market is a valuable source of guidance for individuals and companies in decision framework.
Download Free Table of Content along with List of Tables and Figures @ https://www.databridgemarketresearch.com/toc/?dbmr=global-medical-cannabis-marketThanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.Top Trending Related Reports:
                                    
Legal Marijuana Market Size, Global Industry Growth, Statistics, COVID-19 Trends, Revenue Analysis 2020, Top Companies: VIVO Cannabis, Dr. Hemp Me, QC Infusion, Green Roads, Royal CBD, HempLife Today, Hemp Oil Canada
CBD Oil Market Size 2020-Industry Share, Growth, COVID-19 Trends, Revenue Analysis, Top Leaders-Dr. Hemp Me, Green Roads, Royal CBD, Healthcare Advertising Europe, King CBD: Says DBMR AnalystGlobal CBD Oil Extract Market Size, Share, Growth, Industry By Source Type (Hemp, Marijuana), Distribution Channel (B2B, B2C), End Use (Medical, Personal use, Pharmaceutical, Wellness), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa), Market Trends and Forecast to 2027. Read More @ https://www.databridgemarketresearch.com/reports/global-cbd-oil-extract-marketGlobal CBD Edibles Market Size, Share, Growth, Industry By Source Type (Hemp, Marijuana), Application (Personal Care & Cosmetics, Pharmaceutical, Food & Beverage, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa), Market Trends and Forecast to 2027. Read More @ https://www.databridgemarketresearch.com/reports/global-cbd-edibles-marketGlobal CBD Infused Edible Market Size, Share, Growth, Industry By Source (Hemp, Marijuana), Form (Process Oil, Distillate, Isolate), Grade (Food, Therapeutic), Application (Food & Beverage, Cosmetic & Personal Care, Pharmaceutical, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa), Market Trends and Forecast to 2027. Read More @ https://www.databridgemarketresearch.com/reports/global-cbd-infused-edible-marketGlobal CBD Patch Market Size, Share, Growth, Industry By Type (Layer Drug-in-Adhesive, Reservoir, Others), Application (Chronic Pain, Elevate Mood, Anxiety, Others), Distribution Channel (Conventional Stores, Online Stores, Pharmacies), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2027Global Cannabis Capsule Market Size, Share, Growth, Industry By Product (High THC Capsule, THC/CBD Balanced Capsules, High CBD Capsules Digital), Compound (Tetrahydrocannabinol (THC)-Dominant, Cannabidiol (CBD)-Dominant), Application (Medical, Recreational), End User (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Sales), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2027Global Cannabis Seeds Market Size, Share, Growth, Industry By Type (Whole Cannabis Seeds, Shelled Cannabis Seeds, Cannabis Seeds Oil, Cannabis Seeds Protein), Application (Personal Care Products, Pharmaceuticals), Source (Organic, Conventional), Distribution Channel (Direct Sales, Online, Modern Trade Format, Convenience Stores, Departmental Stores, Retails and Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2027.Global Hemp-based Foods Market Size, Share, Growth, Industry By Product Type (Hemp Seed Oil, Hemp Protein Powder, Whole Hemp Seed, Hulled Hemp Seed, Others),  Distribution Channel (Supermarket Stores, Convenience Stores, Hypermarket Stores, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa), Market Trends and Forecast to 2027. Read More @https://www.databridgemarketresearch.com/reports/global-hemp-based-foods-marketGlobal Cannabis Infused Products Market Size, Share, Growth, Industry By Product (Skincare, Cosmetics, Haircare, Intimate Lubricants, Pharmaceuticals, Gummies, Pills, Infused Beverages, and Other), Source (Hemp, Marijuana), Distribution Channel (B2B, B2C), End User (Medical, Personal Use, Pharmaceuticals, Wellness), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa), Market Trends & Forecast to 2027. Read More @ https://www.databridgemarketresearch.com/reports/global-cannabis-infused-products-marketAbout Data Bridge Market Research:An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Data Bridge Market Research adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client-satisfying rate.Contact Us:                        
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475        
E-Mail: corporatesales@databridgemarketresearch.com

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Cannabis

Emerald Health Therapeutics Announces Stock Option Grant

Newsfile

Published

on

Vancouver, British Columbia–(Newsfile Corp. – August 3, 2020) – Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) (“Emerald”) announces that it has issued an aggregate of 3,800,000 stock options to employees, consultants and directors at an exercise price of $0.21 per common share for a period of five years. All stock options will vest 25% on the date of grant and 25% on the first three anniversaries of the date of grant. Emerald has also granted an aggregate of 175,000 restricted share units to certain employees. The restricted share units will vest one year from the grant date and convert into common shares of Emerald at a fair market value of $0.21 per common share. The stock options and restricted share units have been granted pursuant to Emerald’s Omnibus Incentive Plan which has been previously approved by Emerald’s shareholders and the TSX Venture.

About Emerald Health Therapeutics

Emerald Health Therapeutics, Inc. is committed to creating new consumer experiences with distinct recreational, medical and wellness-oriented cannabis and non-cannabis products, with an emphasis on life science-based innovation and production excellence. Emerald’s three distinct operating assets are designed to uniquely serve the Canadian marketplace and international opportunities. These assets, all in full production, include: its Metro Vancouver, BC-based greenhouse operation (78,000 square feet) capable of producing organic-certified product; Verdélite, its premium craft cannabis production indoor facility in St. Eustache, Québec (88,000 square feet); and Pure Sunfarms, its 41.3%-owned joint venture in Delta, BC, producing high quality, affordably priced products (1.1 M square feet). Its Emerald Naturals subsidiary has launched a new natural wellness product category with its non-cannabis endocannabinoid-supporting product line and is expanding distribution across Canada.

Please visit www.emeraldhealth.ca for more information or contact:

Jenn Hepburn, Chief Financial Officer
(800) 757 3536 Ext. #5

Emerald Investor Relations
(800) 757 3536 Ext. #5
invest@emeraldhealth.ca

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Note Regarding Forward-Looking Statements: Certain statements made in this press release that are not historical facts are forward-looking statements and are subject to important risks, uncertainties and assumptions, both general and specific, which give rise to the possibility that actual results or events could differ materially from our expectations expressed in or implied by such forward-looking statements.

We cannot guarantee that any forward-looking statement will materialize, and readers are cautioned not to place undue reliance on these forward-looking statements. These forward-looking statements involve risks and uncertainties related to, among other things, changes of law and regulations; changes of government; failure to obtain regulatory approvals or permits; failure to obtain necessary financing; results of production and sale activities; results of scientific research; regulatory changes; changes in prices and costs of inputs; demand for labour; demand for products; failure of counter-parties to perform contractual obligations; as well as the risk factors described in Emerald’s annual information form and other regulatory filings. The forward-looking statements contained in this press release represent our expectations as of the date hereof. Forward-looking statements are presented for the purpose of providing information about management’s current expectations and plans and allowing investors and others to obtain a better understanding of our anticipated operating environment. Readers are cautioned that such information may not be appropriate for other purposes. Emerald undertakes no obligations to update or revise such statements to reflect new circumstances or unanticipated events as they occur, unless required by applicable law.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/60965

Continue Reading

Cannabis

PAOG Outlines Strategic Next Steps and Corporate Housecleaning Agenda

Newsfile

Published

on

Sandusky, Ohio–(Newsfile Corp. – August 3, 2020) – PAO Group, Inc. (OTC Pink: PAOG) today released a letter from CEO James C. DiPrima to update shareholders on strategic next steps in addition to reviewing corporate housecleaning agenda items. The letter is included in its entirety below:

Cannot view this image? Visit: https://i2.wp.com/grassnews.net/wp-content/uploads/2020/08/paog-outlines-strategic-next-steps-and-corporate-housecleaning-agenda.jpg?w=740&ssl=1
PAOG New Logo

To view an enhanced version of this graphic, please visit:
https://orders.newsfilecorp.com/files/6729/60946_7bc5829b742ca8b9_001full.jpg

Dear Shareholder,

The last three weeks have been busy for PAOG. Much has been accomplished – a management takeover, and two acquisitions. Expect the momentum to continue. Key contracts moving the company’s acquired cannabis biopharmaceutical technology forward are coming soon.

PAOG anticipates entering into a Contract Research Organization (CRO) agreement as a first step toward initiating an Investigational New Drug Application (IND) to ultimately achieve Food and Drug Administration (FDA) approval for its RespRx Chronic Obstructive Pulmonary Disease (COPD) treatment.

Based on positive results from an informal trial of RexpRX with 25 COVID-19 patients, PAOG also plans to make a Coronavirus Treatment Acceleration Program (CTAP) application after entering into a CRO agreement.

At the same time that we are advancing our cannabis biopharmaceutical technology, we also have some general housekeeping to catch up on. PAOG is behind on its reports required to maintain “current information” status with OTC Markets. We also need to update our website and contact information. We expect to complete all promptly.

A new website is now available. The site is preliminary. Look for continuous updates. Please sign-up for our newsletter and we’ll let you know when to check back.

You can find our new website at www.paogroupinc.com.

Thank you for your interest in our mission to advance the future of medical cannabis technology.

Best Regards,
James C. DiPrima

Forward-Looking Statements: Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the company are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Technical complications, which may arise, could prevent the prompt implementation of any strategically significant plan(s) outlined above. The Company undertakes no duty to revise or update any forward-looking statements to reflect events or circumstances after the date of this release.

Contact Us:
Jim DiPrima
888-272-6472
info@pao.group

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/60946

Continue Reading

Cannabis

Spyder Cannabis Disclosure Update

Newsfile

Published

on

Vaughan, Ontario–(Newsfile Corp. – July 31, 2020) –  Spyder Cannabis Inc. (TSXV: SPDR) (“Spyder” or the “Company“) provides an update to the filing of disclosure documents as a result of COVID-19:

Filing of Annual Disclosure Documents Due to COVID-19

In a press release dated June 25, 2020, the Company announced, among other things, that due to circumstances created by the COVID – 19 pandemic, it would not be filing its April 30, 2020 quarterly report and management discussion and analysis which was due June 29, 2020.

The Company reports that it has yet to file its April 30, 2020 quarterly report and management discussion and analysis to date.

About Spyder Cannabis Inc.

Spyder is a Cannabis, Vape and CBD retailer that operates in jurisdictions where the products are federally legal in both Canada and the United States. The Company, through its subsidiaries, is a retailer involved in the development of three retail business units. The first is the sale of Cannabis products, the second is the sale of CBD in the United States only, the third is the sale of smoking cessation products in Ontario.

Cautionary Statements

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release includes statements containing certain “forward-looking information” within the meaning of applicable securities laws (“forward-looking statements”). Forward- looking statements are frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur.

FOR ADDITIONAL INFORMATION, PLEASE CONTACT:

For more information, please contact:

Spyder Cannabis Inc.
Dan Pelchovitz
President & Chief Executive Officer
Telephone: 1.888.504.7737
Email: corporate@spydercannabis.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/60930

Continue Reading

Trending Online

Grassnews is part of PICANTE Media and Events, a leading media and boutique event organizer in the European Union with a monthly reach of +50,000 readers. The official company (PROSHIRT SRL), has been listed for 4 years in a row among the top 3 Advertising and market research agencies in the local Top Business Romania Microcompanies based on the Financial Reports. Grassnews digests / hand picks the latest news about the CBD / Legal Cannabis industry and serves them to you daily.

Contact us: sales@picante.today

Editorial / PR Submissions

© Grassnews .com 2019 - 2020 - part of PICANTE Media. All rights reserved. Registered in Romania under Proshirt SRL, Company number: 2134306, EU VAT ID: RO21343605. Office address: Blvd. 1 Decembrie 1918 nr.5, Targu Mures, Romania